FDA Inspection 1112255 — Pfizer Ireland Pharmaceuticals Unlimited Company
The FDA completed an inspection of Pfizer Ireland Pharmaceuticals Unlimited Company on Nov 9, 2018 in Dublin 22. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 9, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dublin 22 (Ireland)
Additional details
Mutual Recognition Agreement (MRA)